Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Large Scale Biology Corp. (NasdaqNM:LSBC)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Recent Events
Aug 30Price hit new 52-week low ($3.25)
Location
3333 Vaca Valley Parkway, Suite 1000
Vacaville, CA 95688
Phone: (707) 446-5501
Fax: (707) 446-3917
Employees (last reported count): 144
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 48%
·Over the last 6 months:
 · 5 insider sells; 64.0K shares
  (0.5% of insider shares)
·Institutional: 21% (40% of float)
(55 institutions)
·Net Inst. Selling: 568.0K shares (+12.62%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Large Scale Biology Corporation is using its proteomics and functional genomics technologies to develop products, designed to rapidly and correctly diagnose diseases, as well as implement safe and effective personalized treatment therapies, which can be efficiently delivered. The Company is focused on proteins, the fundamental "nanomachines" of biology that carry out the myriad functions necessary to keep the Company alive. Diseases may arise when made incorrectly, or in the wrong amounts. All biological processes, including diseases and responses to therapeutics, involve changes in proteins. The Company's technologies are in three major areas: Proteomics, the study of proteins in living organisms; Functional genomics, the study of how, when, where and which proteins are made in living organisms, and Biomanufacturing, the production of proteins.
More from Market Guide: Expanded Business Description

Financial Summary
Large Scale Biology Corp. uses its proprietary proteomics and functional genomics technologies to develop products and establish commercial collaborations with pharmaceutical, biotechnology, chemical and other life sciences companies. For the six months ended 6/30/01, revenues rose 6% to $11.9 million. Net loss rose 86% to $6.3 million. Results reflect a slight increase in revenue from the Dow Chemical contract, offset by personnel increases.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Robert Erwin, 47
Chairman, CEO
$184K
William Pfann, 58
CFO, Sr. VP-Fin.
--  
David McGee, Ph.D., 51
Sr. VP, COO, Assistant Sec.
165K
John Rakitan, 56
Sr. VP, Gen. Counsel, Sec.
--  
Pieter Bax, Ph.D.
Sr. VP, Corp. Devel.
--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:LSBCAs of 31-Aug-2001
Price and Volume
52-Week Low
on 30-Aug-2001
$3.25 
Recent Price$3.74 
52-Week High
on 29-Sep-2000
$33.50 
Daily Volume (3-month avg)97.8K
Daily Volume (10-day avg)165.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-88.2%
52-Week Change
relative to S&P500
-84.2%
Share-Related Items
Market Capitalization$91.9M
Shares Outstanding24.6M
Float12.8M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$3.47 
Earnings (ttm)-$0.95 
Earnings (mrq)-$0.16 
Sales (ttm)$1.05 
Cash (mrq)$2.71 
Valuation Ratios
Price/Book (mrq)1.08 
Price/EarningsN/A 
Price/Sales (ttm)3.55 
Income Statements
Sales (ttm)$24.0M
EBITDA (ttm)-$12.9M
Income available to common (ttm)-$19.2M
Profitability
Profit Margin (ttm)-80.0%
Operating Margin (ttm)-91.8%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-22.04%
Return on Equity (ttm)-31.42%
Financial Strength
Current Ratio (mrq)9.68 
Debt/Equity (mrq)0.01 
Total Cash (mrq)$66.6M
Short Interest
As of 8-Aug-2001
Shares Short256.0K
Percent of Float2.0%
Shares Short
(Prior Month)
311.0K
Short Ratio4.74 
Daily Volume54.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.